Dragon Capital Research

Eng
Рус

4C8A GF bid 840,000.00 ask 866,400.00 -
4C8A GR bid 10.20 ask 10.40 -
4K1A GF bid 219.04 ask 229.12 -
5CHA GF bid 18,000.00 ask 20,000.00 -
A2TA GR bid 7.23 ask 7.95 -
ALMK bid 0.06 ask 0.06 -
AVDK bid 3.61 ask 3.63 -
AZOT bid 1.12 ask 1.12 -
AZST bid 0.97 ask 0.97 -
BAVL bid 0.11 ask 0.11 -
CDL LN bid 0.56 ask 0.56 -
CEEN bid 6.02 ask 6.06 -
CGOK bid 6.38 ask 6.95 -
CHIM bid 0.80 ask 0.88 -
DMKD bid 0.12 ask 0.13 -
DNAZ bid 0.03 ask 0.05 -
DNON bid 137.10 ask 190.00 -
DOEN bid 20.55 ask 20.77 -
DOON bid 1.30 ask 4.95 -
DTRZ bid 22.00 ask 38.00 -
ENMZ bid 43.66 ask 43.95 -
FLOT bid 9.60 ask 14.88 -
GSKZ bid 0.05 ask 0.25 -
HANZ bid 0.24 ask 0.40 -
HAON bid 1.03 ask 1.30 -
HRTR bid 1.25 ask 1.28 -
IVFC bid 378.48 ask 378.48 -
KIEN bid 4.20 ask 7.90 -
KREN bid 0.90 ask 1.34 -
KVBZ bid 16.70 ask 17.38 -
LA008 AV bid 3,000.00 ask 4,000.00 -
LAZA bid 0.008 ask 1.04 -
LINS bid 0.16 ask 0.56 -
LTPL bid 2.02 ask 2.17 -
LUAZ bid 0.16 ask 0.20 -
MMKI bid 0.20 ask 0.22 -
MSICH bid 2,496.00 ask 2,507.00 -
MTBD bid 47.80 ask 56.10 -
MYGZ bid 0.16 ask 0.48 -
MZVM bid 0.10 ask 0.12 -
NVTR bid 0.30 ask 0.35 -
OCAB bid 0.16 ask 7.60 -
PGOK bid 14.65 ask 15.20 -
ROGA bid 240.00 ask 400.00 -
SAB08 AV bid 13,000.00 ask 15,000.00 -
SGOK bid 11.90 ask 12.10 -
SHCHZ bid 1.21 ask 1.25 -
SHKD bid 1.15 ask 1.21 -
STIR bid 19.20 ask 20.17 -
SVGZ bid 3.27 ask 3.30 -
UNAF bid 195.30 ask 198.50 -
USCB bid 0.19 ask 0.19 -
UTLM bid 0.32 ask 0.34 -
VKDV bid 2.48 ask 3.04 -
XXIC LN bid 0.06 ask 0.07 -
YASK bid 1.02 ask 1.05 -
ZAEN bid 120.10 ask 133.30 -
ZATR bid 0.96 ask 0.96 -
ZAZA bid 0.08 ask 1.76 -
ZCPK bid 0.40 ask 0.40 -
ZHEN bid 0.82 ask 0.86 -

Companies

Summary

Market Price ($)	2.52
Market Cap ($m)	20.17
Enterprise Value ($m)	20.17
Shares Outstanding	8,004,002
Bloomberg code	KMED UK
Code	KMED

Recommendations

PT ($)	****
Upside (%)	****
Recommendations	****
Ranking	****

Shareholder Structure

Kyivmedpreparat (KMED)

Business Profile

Kyivmedpreparat, Ukraine’s third largest pharmaceuticals producer, accounted for an estimated 8.5% of total domestic pharma output in value terms last year. Together with another local producer, Halychpharm, Kyivmedpreparat forms the Arterium Corporation, which accounted for 3.5% of total domestic pharmaceutical sales in 2010, becoming the fourth-largest company in Ukraine on this measure.

Financial Summary

Indicator	2009	2010	2011E	2012E	2013F
Sales ($m)	53	68	****	****	****
EBITDA ($m)	15	18	****	****	****
Net Income ($m)	5	4	****	****	****
Net Debt ($m)	43	44	****	****	****

Valuation Summary

Indicator	2009	2010	2011E	2012E	2013F
P/E	4.3	4.7	****	****	****
P/Sales	0.38	0.30	****	****	****
EV/EBITDA	4.1	3.6	****	****	****
P/Book	0.38	0.35	****	****	****

Prices are quoted in UAH.

*Data available to Dragon Capital's institutional clients only.

Analyst: Tamara Levchenko

E-mail:

Company Peers

Farmak